Main page content begins

Generics 

Examples of recent deals in the subsector include advising: 

  • Actavis Group and its shareholder on its proposed sale;
  • A leading Indian generic pharmaceutical company in the acquisition of substantially all of the assets of a US-based drug developer, including related development, commercialization and royalty-sharing arrangements;
  • Zydus Cadila on its acquisition of Spanish generics distributor, Laboratories Combix S.L;
  • Healthcare Brands International on their acquisition of Antula Holdings AB;
  • 3i on the acquisition of Active Pharmaceutical Ingredients;
  • Cadila Healthcare Ltd on the acquisition of 100% of Rio de Janeiro based Quimica e Farmaceutica Nikkho do Brasil Ltda by Cadila Healthcare.

Contacts

Nigel Jones

Global Head of Healthcare
IP, London
(44 20) 7456 5804

 

Shane Griffin

Global Head of Healthcare
Corporate, London

(44 20) 7456 5804

 

Jonas Koponen

Global Head of Healthcare
Competition/Antitrust, Brussels
(+32)  250 50227